US5674863A
(en)
*
|
1991-10-18 |
1997-10-07 |
Genentech, Inc. |
Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
|
WO1993013105A1
(fr)
*
|
1991-12-26 |
1993-07-08 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thiophene condense et utilisation pharmaceutique de ce compose
|
US5532240A
(en)
*
|
1991-12-26 |
1996-07-02 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Condensed thiophene compound and pharmaceutical use thereof
|
US6096763A
(en)
*
|
1995-02-23 |
2000-08-01 |
Merck & Co., Inc. |
α1a adrenergic receptor antagonists
|
US5952351A
(en)
*
|
1995-02-23 |
1999-09-14 |
Merck & Co., Inc. |
Alpha 1a adrenergic receptor antagonists
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6699885B2
(en)
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
ZA979781B
(en)
*
|
1996-11-14 |
1998-06-08 |
Akzo Nobel Nv |
Piperidine derivatives.
|
JP5127096B2
(ja)
*
|
1999-04-30 |
2013-01-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
アポトーシスにより誘導される自己免疫疾患を処置するためのベンゾジアゼピンの使用
|
US7572788B2
(en)
|
1999-04-30 |
2009-08-11 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US20050113460A1
(en)
*
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US20040176358A1
(en)
*
|
1999-04-30 |
2004-09-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US20060025388A1
(en)
|
1999-04-30 |
2006-02-02 |
Glick Gary D |
Compositions and methods relating to novel compounds and targets thereof
|
CN100384836C
(zh)
*
|
2000-02-29 |
2008-04-30 |
三菱制药株式会社 |
新型环状酰胺衍生物
|
UA73981C2
(en)
|
2000-03-10 |
2005-10-17 |
Merck Patent Gmbh |
(r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
|
JP2004513915A
(ja)
*
|
2000-11-14 |
2004-05-13 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
複合的な選択的ドーパミンd2レセプターアンタゴニストおよび5−ht1aレセプターアゴニストの新規な使用
|
US7872030B2
(en)
|
2001-07-26 |
2011-01-18 |
Merck Patent Gmbh |
Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20050272723A1
(en)
*
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20060052369A1
(en)
*
|
2004-09-07 |
2006-03-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
AU2006203946B2
(en)
*
|
2005-01-03 |
2009-07-23 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
EP1893218A4
(de)
|
2005-06-01 |
2011-01-12 |
Univ Michigan |
Ungelöste benzodiazepin-zusammensetzungen und verfahren
|
US20070105844A1
(en)
*
|
2005-10-26 |
2007-05-10 |
Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
EP1948191B1
(de)
|
2005-11-01 |
2013-01-16 |
The Regents of the University of Michigan |
Neuartige 1,4-benzodiazepin-2,5-dione mit therapeutischen eigenschaften
|
US8349850B2
(en)
|
2006-03-28 |
2013-01-08 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
US7759338B2
(en)
*
|
2006-04-27 |
2010-07-20 |
The Regents Of The University Of Michigan |
Soluble 1,4 benzodiazepine compounds and stable salts thereof
|
NZ573452A
(en)
|
2006-06-09 |
2011-09-30 |
Univ Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
NZ579507A
(en)
|
2007-03-09 |
2011-11-25 |
Univ Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
EP2896624B1
(de)
*
|
2007-03-28 |
2016-07-13 |
Atir Holding S.A. |
Heterotricyclische Verbindungen als Serotonerge und/oder Dopaminerge Mittel und Anwendungen davon
|
CN101855203B
(zh)
|
2007-09-14 |
2014-03-19 |
密执安州立大学董事会 |
F1f0-atp合成酶抑制剂以及相关的方法
|
UA99839C2
(ru)
|
2007-11-06 |
2012-10-10 |
Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган |
Бензодиазепиноновые соединения, применяемые при лечении кожных состояний
|
EP2352724B1
(de)
|
2008-09-11 |
2015-04-22 |
The Regents of the University of Michigan |
Arylguanidine-f1f0-aptase inhibitoren und deren therapeutischen verwendung
|
WO2010121164A2
(en)
|
2009-04-17 |
2010-10-21 |
The Regents Of The University Of Michigan |
1,4-benzodiazepinone compounds and their use in treating cancer
|
WO2011035124A1
(en)
|
2009-09-18 |
2011-03-24 |
The Regents Of The University Of Michigan |
Benzodiazepinone compounds and methods of treatment using same
|
WO2011062766A2
(en)
|
2009-11-17 |
2011-05-26 |
The Regents Of The University Of Michigan |
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
|
CA2780333C
(en)
|
2009-11-17 |
2016-05-24 |
The Regents Of The University Of Michigan |
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
|
EP2697206B1
(de)
|
2011-04-10 |
2019-04-03 |
Atir Holding S.A. |
Heterocyclische verbindungen und ihre verwendung bei der behandlung von sexuellen funktionsstörungen
|
JP7015092B2
(ja)
|
2016-07-28 |
2022-02-02 |
塩野義製薬株式会社 |
ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物
|
WO2019146740A1
(ja)
|
2018-01-26 |
2019-08-01 |
塩野義製薬株式会社 |
ドーパミンd3受容体拮抗作用を有する環式化合物
|
TW201938537A
(zh)
|
2018-01-26 |
2019-10-01 |
日商鹽野義製藥股份有限公司 |
具有多巴胺d3受體拮抗作用的稠環化合物
|
US10745401B2
(en)
|
2018-07-23 |
2020-08-18 |
Sumitomo Dainippon Pharma Co., Ltd. |
Condensed lactam derivative
|
JP7387605B2
(ja)
|
2018-07-23 |
2023-11-28 |
住友ファーマ株式会社 |
縮環ラクタム誘導体
|